Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.
about
Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomasc-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutationsImmunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma.Targeted therapy for cancer: the gastrointestinal stromal tumor model.MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulationSynovial sarcoma: from genetics to genetic-based animal modelingTyrosine kinase inhibitors in pediatric malignancies.Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation.Advances in therapy for pediatric sarcomas.A novel multi-kinase inhibitor pazopanib suppresses growth of synovial sarcoma cells through inhibition of the PI3K-AKT pathway.Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma.Molecular characterization of synovial sarcoma in children and adolescents: evidence of akt activation.Sarcomas of the head and neck in adult patients: current concepts and future perspectives.Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signalingDownstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy.Platelet-derived growth factor signaling in human malignanciesTRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland Carcinoma.Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.
P2860
Q26825000-F5B88249-7DE9-4E9A-A076-8783EC0990CDQ27649203-BECB197C-0B26-4F31-8ED0-034047D9203BQ33275402-EB634029-43D2-4529-B7F9-D38B62BEDB2EQ33807742-423B7827-EB58-4B85-BA7A-6509FCC4BD2BQ34212635-5AF106CD-28A3-49B8-9003-B5668487949EQ34593303-9925D821-8A6B-4638-BEB6-6A3699F230A0Q36977823-E4AE226C-1302-452D-8948-285E70C97F0DQ37181235-A416713E-F4E1-4EE2-A75F-2C40F753B5EBQ37500347-8FBDAD93-4ABD-4F4C-89B5-4A01EB646D0CQ38217354-CBEB6AFF-50C6-4991-9E58-DBD62C3ADE4CQ39391651-09C812DB-1B72-449B-BE45-1AB38158291EQ39624408-AAF2DC36-6D9D-4FBF-82CC-5F51B9A58D48Q39960404-0D35538A-B04C-4AEC-9201-408431032E88Q40059961-979CA8EA-9E2F-47DE-BE43-D77E6CAB68F1Q41412661-9801FC11-8817-43E3-8280-DA4573818F08Q41918438-ACE724FE-410C-4C69-B039-8BEFEC1C3386Q42418059-5FBA13D7-1A0F-4868-9D0A-2B685F630EC5Q42434702-17D612B0-10A4-434C-A08E-D99BAF61EE81Q42835389-3D46A0CE-BC58-4150-BBE6-15413291C95A
P2860
Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Expression of ligand-activated ...... receptors in synovial sarcoma.
@en
type
label
Expression of ligand-activated ...... receptors in synovial sarcoma.
@en
prefLabel
Expression of ligand-activated ...... receptors in synovial sarcoma.
@en
P2093
P50
P1476
Expression of ligand-activated ...... receptors in synovial sarcoma.
@en
P2093
Carla Riva
Lorena Bonadiman
Silvana Pilotti
P304
P356
10.1158/1078-0432.CCR-03-0059
P407
P50
P577
2004-02-01T00:00:00Z